5.84

0.86% +0.0498

Precipio Inc (PRPO)

Overview News Price History Financials Discussions Forecast Stock Split

Precipio Inc stock is currently priced at $5.84, with a 24-hour trading volume of 4,460. It has seen a +0.86% increased in the last 24 hours and a -10.02% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $5.79 pivot point. If it approaches the $5.79 resistance level, significant changes may occur.

Previous Close:

$5.7902

Open:

$5.74

24h Volume:

4,460

Market Cap:

$8.50M

Revenue:

$15.20M

Net Income/Loss:

$-5.85M

P/E Ratio:

-0.6348

EPS:

-9.2

Net Cash Flow:

$-3.69M

1W Performance:

+2.82%

1M Performance:

-10.02%

6M Performance:

-12.97%

1Y Performance:

+1,198%

1D Range:

$5.61

$5.92

52W Range:

$0.2505

$8.99

Precipio Inc Stock (PRPO) Company Profile

Name

Precipio Inc

Sector

Healthcare (1218)

Industry

Diagnostics & Research (67)

Phone

203 787 7888

Address

4 Science Park, 3rd Floor, New Haven, CT

Employee

Twitter

@precipiodx

Next Earnings Date

2024-06-13

Latest SEC Filings

PRPO's Discussions on Twitter

Precipio Inc Stock (PRPO) Latest News

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

GlobeNewswire Inc.

Precipio faces $100,000 cost if shareholder meeting delayed By Investing.com - Investing.com UK

Investing.com UK

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

GlobeNewswire Inc.

Precipio on track for mid-year breakeven after setbacks By Investing.com - Investing.com

Investing.com

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet - Simply Wall St

Simply Wall St

It's Probably Less Likely That Precipio, Inc.'s (NASDAQ:PRPO) CEO Will See A Huge Pay Rise This Year - Yahoo Finance

Yahoo Finance

Precipio Inc Stock (PRPO) Financials Data

Precipio Inc (PRPO) Revenue 2024

PRPO reported a revenue (TTM) of $15.20 million for the quarter ending December 31, 2023, a +61.46% rise year-over-year.

Precipio Inc (PRPO) Net Income 2024

PRPO net income (TTM) was -$5.85 million for the quarter ending December 31, 2023, a +52.04% increase year-over-year.

Precipio Inc (PRPO) Cash Flow 2024

PRPO recorded a free cash flow (TTM) of -$3.69 million for the quarter ending December 31, 2023, a +53.93% increase year-over-year.

Precipio Inc (PRPO) Earnings per Share 2024

PRPO earnings per share (TTM) was -$4.56 for the quarter ending December 31, 2023, a +56.98% growth year-over-year.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.